TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A preclinical study from MD Anderson Cancer Center found that a 24-hour fast, together with the gut bacterium Akkermansia muciniphila, activated intestinal cell programs associated with repair after radiation damage. The findings have not been tested as a treatment in people, and researchers say more work is needed to establish safety and benefit for cancer patients.
Researchers at The University of Texas MD Anderson Cancer Center report that a 24-hour fast, together with the gut bacterium Akkermansia muciniphila, activated intestinal cell programs linked to tissue repair after radiation exposure in preclinical research. The finding points to a possible way to protect healthy intestine during cancer treatment, but it has not established that fasting or the bacterium improves outcomes in patients.
The study, published in the Proceedings of the National Academy of Sciences, was co-led by Helen Piwnica-Worms, a professor of Experimental Radiation Oncology, and Kunal Rai, a professor of Genomic Medicine. The researchers examined why fasting had appeared to help intestinal recovery in earlier preclinical work from Piwnica-Worms’ laboratory.
In the reported experiments, a 24-hour fast increased the abundance of Akkermansia muciniphila, also called AKK, in the small intestine. The bacterium produces propionate, a molecule the study links to changes in intestinal cells. Alongside other metabolic changes associated with fasting, these changes affected histones, proteins that package DNA and help regulate which genes cells can activate.
The researchers found that fasting was associated with a larger population of intestinal cells carrying programs related to regeneration. After radiation exposure, these prepared cells could expand and help rebuild the damaged lining, according to the study’s account. When researchers selectively removed AKK, fasting no longer produced the same regenerative benefit; the response returned only when the bacterium was restored along with fasting. This points to a joint effect in the experimental model, not proof that either fasting or the microbe alone protects people.
A Possible Route to Protect Healthy Intestine
Radiation is used to treat cancers in the abdomen, including pancreatic, colorectal and gynecologic cancers. It can also injure nearby healthy tissue. Damage to the small intestine’s lining can be associated with nausea, diarrhea and infection, and severe injury can lead to serious complications. Such risks may limit how much radiation clinicians can safely deliver.
The study offers a possible biological explanation for how fasting could prime intestinal cells to respond to injury. If the mechanism can be shown to work safely in people, it might help researchers develop approaches to reduce treatment-related harm. The work also raises the possibility of targeting AKK or propionate rather than asking patients to fast. Those are research possibilities, not available clinical options established by this study.
Researchers are also interested in whether similar repair pathways could apply to other tissues affected by cancer treatment, including bone marrow. The current findings concern intestinal recovery in preclinical research; they do not show that fasting makes radiation therapy safer or more effective for patients, or that it protects tumors from treatment.
Products Worth Considering
Garmin Forerunner 170 GPS Running Smartwatch Bundle, Whitestone
Bowflex SelectTech 840 Adjustable Kettlebell
Garmin Forerunner 965 GPS Multisport Smartwatch with AMOLED Display and Charging Bundle
As an affiliate, we earn on qualifying purchases.
From Earlier Fasting Results to a Microbe
Radiation can damage rapidly renewing cells in the small intestine as well as cancer cells. The intestine’s protective lining is particularly vulnerable, making its recovery relevant to patients receiving radiation to abdominal areas. The reported study builds on earlier preclinical research from the same laboratory that found fasting before radiation exposure helped the intestine recover.
That earlier work left open how food restriction might produce the effect. The new research identifies a connection among fasting, AKK abundance and changes in gene regulation linked to regeneration. Histone modifications can affect whether genes are accessible for activation without changing the underlying DNA sequence. In this study, that process is presented as part of the proposed repair response, rather than a demonstrated treatment effect in humans.
The authors say the pathway might eventually be activated through dietary approaches, targeted microbes or microbial products. The report also notes that fasting may not be practical for people receiving cancer care, which is one reason researchers are considering alternatives. No patient intervention or clinical benefit is established in the source material.
“Fasting helps prepare intestinal cells to respond more quickly and effectively after injury, almost like training the cells with an emergency preparedness plan.”
— Helen Piwnica-Worms, co-leader of the study and professor of Experimental Radiation Oncology at MD Anderson
Human Benefits Remain Unproven
The research is preclinical, and the source report does not establish that the same mechanism operates in people. It remains unclear whether fasting, AKK, propionate or a combination could safely reduce intestinal injury during cancer treatment, and whether any such approach would affect cancer-treatment outcomes.
The report does not provide evidence that patients should fast before radiation, nor does it specify a tested fasting protocol for clinical use. Food restriction during cancer care may be impractical, as Rai noted. The source also does not give clinical-trial results, patient numbers or evidence that a microbial treatment is ready for testing or use. Further studies are needed before the findings can support recommendations for patients.
Testing the Pathway Before Patient Trials
Researchers say additional studies are needed to determine whether the repair mechanism is present in humans and whether it can be activated safely. If further work supports the findings, later clinical trials could examine approaches for patients receiving abdominal radiation. The source describes such trials as a future possibility, not a scheduled next step.
Research could also test whether targeted microbes or their metabolites can produce a similar response without requiring fasting, and whether related mechanisms apply to other vulnerable tissues. Until those questions are answered, the findings remain a potential lead for research rather than a basis for changing cancer treatment or dietary decisions.
Key Questions
What did the study find about a 24-hour fast?
In preclinical research, a 24-hour fast was linked to changes in intestinal cells associated with regeneration after radiation exposure. The study also found that the bacterium Akkermansia muciniphila was needed for the reported benefit in the experimental model.
Does the finding show that fasting helps cancer patients?
No. The research is preclinical and does not establish that fasting protects the intestines or improves treatment outcomes in people. Researchers say more studies are needed before testing clinical benefit and safety.
What role did Akkermansia muciniphila play?
The study linked the bacterium, also called AKK, to production of propionate and changes in intestinal cells associated with repair. Removing AKK eliminated the fasting-related regenerative benefit in the reported experiments; restoring it along with fasting brought the response back.
Should patients fast before radiation treatment?
The study does not provide a recommendation for patients to fast. It has not established a safe or effective clinical fasting plan, and the researchers say food restriction may not be practical for cancer patients. Patients should discuss dietary decisions during treatment with their care team.
Could researchers pursue an approach that does not involve fasting?
Yes. The researchers say targeted microbes or molecules produced by them could be investigated as alternatives. Those approaches are potential research directions; the source does not report that they have been shown to protect patients.
Source: sciencedaily.com
